feed,title,long_url,short_url
Investors,Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study,https://www.investors.com/news/technology/novo-nordisk-stock-semaglutide-weight-loss-drug-dementia-risk/,https://da.gd/ggdWJ
